Is this your firm? Get featured or correct your listing →
We track CPPIB but have little verified detail yet.
Value Add Research
Latest Pulse
- Sep 21, 2026Intrepid Growth Partners Closes $525M Debut FundIntrepid Growth Partners, founded by former CPP Investments CEO Mark Machin, closed its debut fund at $525 million (announced September 14) to back growth-stage AI founders, with backers including Temasek and Abu Dhabi's investment authority.→
- Sep 6, 2026Fintech's $1.36B Week, Led by FNZ's $450MWealthTech giant FNZ took the largest of twelve fintech rounds this week at $450 million, in a period where US companies made up seven of the twelve deals and wealth-management platforms dominated the category mix.→
- Jul 30, 2026Zhongji Innolight Slides on Its $6.8B Hong Kong DebutZhongji Innolight, the world's top optical-interconnect supplier, raised $6.8 billion in Hong Kong's biggest listing in seven years, but shares fell as much as 5% on debut as the global AI-stock selloff overshadowed the offering.→
- Jul 13, 2026Helsing Raises $1.8B, Europe's Biggest Defense RoundMunich-based Helsing closed a $1.8 billion Series E at an $18 billion valuation, Europe's biggest-ever defense-tech round, with Goldman Sachs Alternatives, CPPIB and JPMorgan joining as new investors amid oversubscribed demand.→
- Jul 1, 2026Bain, CPP and Bristol Myers Add $126M to Beeline's Lupus PipelineBeeline Medicines closed a $126.3 million Series A extension from Bain Capital, CPP Investments and Bristol Myers Squibb, upsizing its total Series A to $426.3 million to fund pivotal development of afimetoran in lupus ahead of a Phase 2 readout expected in.→